Merck granted Fast Track Designation by the U.S. FDA for MK-2214 for the treatment of Alzheimer's disease RAHWAY, N.J., ...

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, announces new neuroimaging data from its ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Americans are more likely to visit their eye doctor than their primary care provider. And that’s one big reason why a company ...

Regular physical activity in midlife and older adulthood may cut dementia risk by up to 45%, showing it’s never too late to ...

As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...